T37.1X2A Poisoning by antimycobacterial drugs, intentional self-harm, initial encounter

Name of the Condition

• Poisoning by antimycobacterial drugs, intentional self-harm, initial encounter

Summary

This condition involves intentional self-harm through poisoning by antimycobacterial medications, typically used to treat mycobacterial infections like tuberculosis. It represents an initial encounter with acute toxic exposure resulting from deliberate self-inflicted harm, focusing on the acute effects during the first episode of care.

Causes

Intentional self-harm poisoning may result from deliberate overdose or misuse of antimycobacterial drugs. This can occur due to intentional ingestion of these medications, often in the context of suicidal ideation or self-harm behaviors. Drug interactions or allergic reactions may exacerbate the toxicity, but the primary cause is intentional exposure.

Risk Factors

• History of mental health conditions, such as depression or suicidal ideation.
• Access to antimycobacterial medications without proper storage or supervision.
• Prior episodes of self-harm or substance misuse.
• Social or environmental stressors contributing to intentional harm.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Systemic: Organ-specific toxicity (e.g., hepatic or renal impairment), hypotension, or respiratory distress.

Diagnosis

Clinical evaluation focuses on medication history, symptom onset, and lab tests (e.g., drug levels, organ function). Toxicology screening confirms exposure, while imaging or other studies assess organ damage. A thorough psychosocial assessment is critical to determine intent and guide care.

Treatment Options

Treatment includes immediate medical stabilization (e.g., airway management, supportive care) and specific interventions (e.g., activated charcoal, antidotes if available). Psychiatric evaluation and crisis intervention are essential, with ongoing mental health support and safety planning.

Prognosis and Follow-Up

Prognosis depends on the severity of poisoning, timeliness of care, and underlying mental health status. Follow-up involves monitoring for organ damage, medication adjustments, and ongoing psychiatric care to address self-harm risk and prevent recurrence.

Complications

• Severe organ toxicity (e.g., hepatic or renal failure).
• Neurological damage or persistent cognitive impairment.
• Psychiatric complications, such as recurrent self-harm or suicidal behavior.
• Long-term disability from acute toxicity or treatment sequelae.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Patient education on safe medication handling and disposal.
• Regular mental health screening and support for at-risk individuals.
• Collaboration with healthcare providers to address underlying psychosocial concerns.

When to Seek Professional Help

Seek immediate medical attention for suspected poisoning, especially with intentional self-harm. Contact emergency services or a healthcare provider if symptoms like severe nausea, confusion, seizures, or altered consciousness occur. Prompt care is critical to mitigate toxicity and address mental health needs.

Tips for Medical Coders

Document the intent (intentional self-harm) and encounter type (initial) clearly in the medical record. Ensure specificity of the antimycobacterial drug involved, if known, and note the acute nature of the poisoning. Verify that the code aligns with clinical documentation to reflect the intentional self-harm and initial encounter context accurately.